$60.09
+0.45
(+0.75%)▲
0.17%
Downside
Day's Volatility :1.83%
Upside
1.67%
33.95%
Downside
52 Weeks Volatility :39.75%
Upside
8.79%
Period | Ambarella, Inc. | Sector (Technology) | Index (Russel 2000) |
---|---|---|---|
3 Months | -6.55% | -0.2% | 0.0% |
6 Months | 30.82% | 16.0% | 0.0% |
1 Year | 11.9% | 38.7% | 0.0% |
3 Years | -64.3% | 50.0% | -21.9% |
Market Capitalization | 2.5B |
Book Value | $13.27 |
Earnings Per Share (EPS) | -4.36 |
PEG Ratio | 4.97 |
Wall Street Target Price | 74.0 |
Profit Margin | -79.46% |
Operating Margin TTM | -56.94% |
Return On Assets TTM | -14.8% |
Return On Equity TTM | -30.46% |
Revenue TTM | 220.4M |
Revenue Per Share TTM | 5.43 |
Quarterly Revenue Growth YOY | 2.6% |
Gross Profit TTM | 212.0M |
EBITDA | -145.9M |
Diluted Eps TTM | -4.36 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -0.91 |
EPS Estimate Next Year | -0.86 |
EPS Estimate Current Quarter | -0.19 |
EPS Estimate Next Quarter | 0.0 |
What analysts predicted
Upside of 23.15%
FY19 | Y/Y Change | |
---|---|---|
Revenue | 227.8M | ↓ 22.9% |
Net Income | -30.4M | ↓ 261.51% |
Net Profit Margin | -13.37% | ↓ 19.75% |
FY20 | Y/Y Change | |
---|---|---|
Revenue | 228.7M | ↑ 0.42% |
Net Income | -44.8M | ↑ 47.11% |
Net Profit Margin | -19.58% | ↓ 6.21% |
FY21 | Y/Y Change | |
---|---|---|
Revenue | 223.0M | ↓ 2.51% |
Net Income | -59.8M | ↑ 33.47% |
Net Profit Margin | -26.81% | ↓ 7.23% |
FY22 | Y/Y Change | |
---|---|---|
Revenue | 331.9M | ↑ 48.82% |
Net Income | -26.4M | ↓ 55.82% |
Net Profit Margin | -7.96% | ↑ 18.85% |
FY23 | Y/Y Change | |
---|---|---|
Revenue | 337.6M | ↑ 1.73% |
Net Income | -65.4M | ↑ 147.57% |
Net Profit Margin | -19.37% | ↓ 11.41% |
FY24 | Y/Y Change | |
---|---|---|
Revenue | 226.5M | ↓ 32.92% |
Net Income | -169.4M | ↑ 159.1% |
Net Profit Margin | -74.81% | ↓ 55.44% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Revenue | 62.1M | ↓ 25.42% |
Net Income | -35.9M | ↑ 223.3% |
Net Profit Margin | -57.77% | ↓ 44.44% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Revenue | 62.1M | ↓ 0.03% |
Net Income | -31.2M | ↓ 13.1% |
Net Profit Margin | -50.22% | ↑ 7.55% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Revenue | 50.6M | ↓ 18.55% |
Net Income | -41.7M | ↑ 33.69% |
Net Profit Margin | -82.44% | ↓ 32.22% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Revenue | 51.6M | ↑ 2.02% |
Net Income | -60.6M | ↑ 45.31% |
Net Profit Margin | -117.42% | ↓ 34.98% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Revenue | 54.5M | ↑ 5.54% |
Net Income | -37.9M | ↓ 37.41% |
Net Profit Margin | -69.63% | ↑ 47.79% |
Q3 FY24 | Q/Q Change | |
---|---|---|
Revenue | 63.7M | ↑ 16.98% |
Net Income | -34.9M | ↓ 8.02% |
Net Profit Margin | -54.75% | ↑ 14.88% |
FY19 | Y/Y Change | |
---|---|---|
Total Assets | 466.9M | ↓ 14.6% |
Total Liabilities | 47.4M | ↓ 26.52% |
FY20 | Y/Y Change | |
---|---|---|
Total Assets | 527.3M | ↑ 12.94% |
Total Liabilities | 79.2M | ↑ 67.22% |
FY21 | Y/Y Change | |
---|---|---|
Total Assets | 573.3M | ↑ 8.72% |
Total Liabilities | 98.3M | ↑ 24.11% |
FY22 | Y/Y Change | |
---|---|---|
Total Assets | 657.5M | ↑ 14.7% |
Total Liabilities | 110.4M | ↑ 12.27% |
FY23 | Y/Y Change | |
---|---|---|
Total Assets | 710.2M | ↑ 8.01% |
Total Liabilities | 104.1M | ↓ 5.67% |
FY24 | Y/Y Change | |
---|---|---|
Total Assets | 657.7M | ↓ 7.4% |
Total Liabilities | 97.8M | ↓ 6.07% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 704.8M | ↓ 0.76% |
Total Liabilities | 98.6M | ↓ 5.3% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 696.2M | ↓ 1.21% |
Total Liabilities | 93.9M | ↓ 4.73% |
Q4 FY23 | Q/Q Change | |
---|---|---|
Total Assets | 684.6M | ↓ 1.67% |
Total Liabilities | 92.8M | ↓ 1.16% |
Q1 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 657.7M | ↓ 3.94% |
Total Liabilities | 97.8M | ↑ 5.32% |
Q2 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 638.7M | ↓ 2.89% |
Total Liabilities | 83.2M | ↓ 14.88% |
Q3 FY24 | Q/Q Change | |
---|---|---|
Total Assets | 650.3M | ↑ 1.83% |
Total Liabilities | 102.8M | ↑ 23.49% |
FY19 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 24.5M | ↓ 71.35% |
Investing Cash Flow | -79.1M | ↑ 724.4% |
Financing Cash Flow | -98.0M | ↑ 88.36% |
FY20 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 39.4M | ↑ 61.06% |
Investing Cash Flow | -8.6M | ↓ 89.16% |
Financing Cash Flow | 6.5M | ↓ 106.65% |
FY21 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 30.8M | ↓ 21.86% |
Investing Cash Flow | -31.3M | ↑ 265.25% |
Financing Cash Flow | 10.4M | ↑ 59.55% |
FY22 | Y/Y Change | |
---|---|---|
Operating Cash Flow | 38.8M | ↑ 25.96% |
Investing Cash Flow | -119.6M | ↑ 281.66% |
Financing Cash Flow | 10.5M | ↑ 1.24% |
Q2 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | 22.0M | ↑ 332.71% |
Investing Cash Flow | -8.2M | ↑ 0.91% |
Financing Cash Flow | 385.0K | ↓ 89.74% |
Q3 FY23 | Q/Q Change | |
---|---|---|
Operating Cash Flow | -6.8M | ↓ 131.05% |
Investing Cash Flow | 241.0K | ↓ 102.94% |
Financing Cash Flow | 1.4M | ↑ 256.1% |
Sell
Neutral
Buy
Ambarella, Inc. is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
---|---|---|---|---|---|
Ambarella, Inc. | 12.61% | 30.82% | 11.9% | -64.3% | 9.85% |
Entegris, Inc. | 1.18% | -17.29% | 14.37% | -16.22% | 132.28% |
Applied Materials, Inc. | 14.03% | 3.99% | 51.7% | 62.54% | 304.25% |
Lam Research Corporation | 12.99% | -12.39% | 31.7% | 46.85% | 254.06% |
Teradyne Inc. | 4.42% | 27.98% | 37.77% | 17.31% | 116.63% |
Kla-tencor Corporation | 9.14% | 18.46% | 63.62% | 144.22% | 394.42% |
Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
---|---|---|---|---|---|---|---|---|
Ambarella, Inc. | NA | NA | 4.97 | -0.91 | -0.3 | -0.15 | NA | 13.27 |
Entegris, Inc. | 89.88 | 89.88 | 1.58 | 3.13 | 0.05 | 0.04 | 0.0 | 23.22 |
Applied Materials, Inc. | 24.03 | 24.03 | 1.89 | 8.53 | 0.44 | 0.15 | 0.01 | 22.85 |
Lam Research Corporation | 28.57 | 28.57 | 1.64 | 29.71 | 0.46 | 0.14 | 0.01 | 6.55 |
Teradyne Inc. | 43.53 | 43.53 | 1.13 | 3.02 | 0.19 | 0.09 | 0.0 | 16.88 |
Kla-tencor Corporation | 39.68 | 39.68 | 1.65 | 23.28 | 0.88 | 0.15 | 0.01 | 25.06 |
Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
---|---|---|---|---|---|
Ambarella, Inc. | Buy | $2.5B | 9.85% | NA | -79.46% |
Entegris, Inc. | Buy | $16.8B | 132.28% | 89.88 | 5.61% |
Applied Materials, Inc. | Buy | $176.3B | 304.25% | 24.03 | 27.74% |
Lam Research Corporation | Buy | $111.1B | 254.06% | 28.57 | 25.68% |
Teradyne Inc. | Buy | $21.8B | 116.63% | 43.53 | 18.33% |
Kla-tencor Corporation | Buy | $111.2B | 394.42% | 39.68 | 28.15% |
Insights on Ambarella, Inc.
Revenue is up for the last 4 quarters, 50.59M → 63.72M (in $), with an average increase of 7.3% per quarter
Netprofit is up for the last 3 quarters, -60.60M → -34.88M (in $), with an average increase of 34.3% per quarter
In the last 1 year, Kla-tencor Corporation has given 70.4% return, outperforming this stock by 56.7%
In the last 3 years, Kla-tencor Corporation has given 152.1% return, outperforming this stock by 216.1%
Vanguard Group Inc
BlackRock Inc
State Street Corp
Millennium Management LLC
Manufacturers Life Insurance Co
Morgan Stanley - Brokerage Accounts
Ambarella, Inc.’s price-to-earnings ratio stands at None
Read Moreambarella, inc. (nasdaq:amba), is a leading developer of low-power, high-definition (hd) and ultra hd video compression and image processing solutions. the company's products are used in a variety of hd cameras including security ip-cameras, sports cameras, wearable cameras, flying cameras and automotive video camera recorders. ambarella compression chips are also used in broadcasting tv programs worldwide. for more information about ambarella, please visit www.ambarella.com.
Organization | Ambarella, Inc. |
Employees | 915 |
CEO | Dr. Feng-Ming Wang Ph.D. |
Industry | Electronic Technology |
Berry Plastics Group, Inc.
$60.09
+0.75%
Dnp Select Income Closed Fund
$60.09
+0.75%
Geron Corporation
$60.09
+0.75%
Ishares S&p Mid-cap 400 Growth Etf
$60.09
+0.75%
Box, Inc.
$60.09
+0.75%
Payoneer Global Inc.
$60.09
+0.75%
Janus Henderson Group Plc
$60.09
+0.75%
S&p Biotech Spdr Etf
$60.09
+0.75%
First Trust Capital Strength
$60.09
+0.75%